Detection bias may explain raised bladder CA risk in T2DM

September 17, 2013
Detection bias may explain raised bladder CA risk in T2DM
Early detection bias may explain the pattern of increased bladder cancer risk previously reported in patients with type 2 diabetes, according to a study published online Aug. 29 in Diabetes Care.

(HealthDay)—Early detection bias may explain the pattern of increased bladder cancer risk previously reported in patients with type 2 diabetes, according to a study published online Aug. 29 in Diabetes Care.

Isabelle N. Colmers, from the University of Alberta in Edmonton, Canada, and colleagues used linked administrative databases (1996 to 2006) to create a cohort of 185,100 adults from British Columbia, Canada, with incident , who were age-, sex-, and index date-matched to individuals without in a 1:1 ratio. During annual time windows following the index date, the incidence rates and hazard ratios for bladder cancer were calculated.

During a median follow-up of four years, the researchers found that within the study population (54 percent men; average age, 60.7 years) 1,171 new bladder cancer cases were diagnosed. Bladder cancer incidence in the diabetes cohort was 85.3 per 100,000 person-years in the first year after diabetes diagnosis, compared with 66.1 in the control cohort (adjusted hazard ratio, 1.30; P = 0.03). The increased bladder cancer risk seen in the first year was limited to those with the fewest physician visits two years prior to the index date (?12 visits, adjusted hazard ratio, 2.14; P = 0.003). Type 2 diabetes was not associated with bladder cancer after the first year.

"The results suggest that early detection bias may account for an overestimation in previously reported increased risks of associated with type 2 diabetes," the authors write.

Explore further: Some diabetes drugs may increase risk of bladder cancer

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Some diabetes drugs may increase risk of bladder cancer

July 3, 2012

An increased risk of bladder cancer is linked to the use of pioglitazone, a medication commonly used to treat type 2 diabetes, according to a new study published in CMAJ (Canadian Medical Association Journal).

Study assesses bidirectional link for diabetes, depression

November 19, 2012

(HealthDay)—There is a bidirectional relationship between type 2 diabetes and depression, with a stronger correlation for depression predicting diabetes onset, according to research published online Nov. 12 in Diabetes ...

Leukocyte telomere length linked to diabetes risk

August 23, 2013

(HealthDay)—For American Indians, leukocyte telomere length is associated with the risk of incident diabetes, with an almost two-fold increased risk for those with the shortest versus the longest length, according to a ...

Recommended for you

New theory on how insulin resistance, metabolic disease begin

September 26, 2016

Does eating too much sugar cause type 2 diabetes? The answer may not be simple, but a study published Sept. 26 in the Journal of Clinical Investigation adds to growing research linking excessive sugar consumption—specifically ...

Unique molecular atlas of pancreas produced

September 23, 2016

Researchers at Karolinska Institutet have managed to produce the first molecular map of the genes that are active in the various cells of the human pancreas. They have also revealed differences in genetic activity between ...

Can long naps cause diabetes?

September 14, 2016

A study presented at a scientific congress Thursday reported a link between long naps and a higher risk of diabetes, though it couldn't say if daytime sleeping was a symptom or a cause.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.